4.7 Article

Untargeted Multiomics Approach Coupling Lipidomics and Metabolomics Profiling Reveals New Insights in Diabetic Retinopathy

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Chemistry, Multidisciplinary

Multiplatform untargeted metabolomics

Micah J. Jeppesen et al.

Summary: Metabolomics samples contain thousands of metabolites, but single analytical techniques can only characterize a few hundred. This limitation can be overcome by using a multiplatform approach and employing synergistic sample preparation and multiple probabilistic methods for peak detection and metabolite identification. However, the analysis of large data sets from different analytical techniques presents challenges in data processing and requires the use of multivariate analysis methods.

MAGNETIC RESONANCE IN CHEMISTRY (2023)

Article Multidisciplinary Sciences

Novel insights into the mechanisms of hard exudate in diabetic retinopathy: Findings of serum lipidomic and metabolomics profiling

Yinchen Shen et al.

Summary: This study aims to identify differential serum lipids and metabolites associated with retinal hard exudates (HEs) in diabetic retinopathy (DR). Specific lipids and metabolites were found to be associated with the occurrence of HEs, and may serve as predictive biomarkers in the early stage of HEs.

HELIYON (2023)

Article Medicine, Research & Experimental

Identification of serum metabolome signatures associated with retinal and renal complications of type 2 diabetes

Yoshihiko Tomofuji et al.

Summary: This study identifies differences in blood metabolites between individuals with type 2 diabetes and the complications of diabetic retinopathy and diabetic kidney disease compared to those without complications. The analysis reveals a specific metabolic pathway associated with these complications, highlighting the potential for using metabolites as biomarkers.

COMMUNICATIONS MEDICINE (2023)

Review Endocrinology & Metabolism

Lipids, hyperreflective crystalline deposits and diabetic retinopathy: potential systemic and retinal-specific effect of lipid-lowering therapies

Alicia J. Jenkins et al.

Summary: Clinical studies provide limited and sometimes conflicting evidence on the relationship between circulating lipid levels and the development of diabetic retinopathy. Trials focused on the cardiovascular system suggest that lipid-lowering therapies may have a protective effect, but trials with ocular primary endpoints are still ongoing.

DIABETOLOGIA (2022)

Article Ophthalmology

Plasma Arginine and Citrulline are Elevated in Diabetic Retinopathy

A. Brantley Milam et al.

Summary: This study aimed to investigate the differences in six arginine-related and citrulline-related metabolites between patients with type 2 diabetes and diabetic retinopathy. The results showed that plasma levels of arginine and citrulline were significantly elevated in patients with diabetic retinopathy.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2022)

Review Ophthalmology

The prevalence of retinopathy in prediabetes: A systematic review

Varo Kirthi et al.

Summary: This study aimed to determine the prevalence of retinopathy in adults with prediabetes. The results showed a wide range of prevalence estimates, indicating significant variation across different studies due to differences in screening methods, grading protocols, and study populations.

SURVEY OF OPHTHALMOLOGY (2022)

Article Biochemistry & Molecular Biology

Early Metabolomic Markers of Acute Low-Dose Exposure to Uranium in Rats

Stephane Grison et al.

Summary: Metabolomics changes in rats following acute low-dose uranium exposure were studied to identify early biomarkers and altered metabolic pathways. The study found that low doses of uranium lead to time-based non-toxic biological effects, which can be used for identifying early and delayed exposure markers and for predicting uranium exposure.

METABOLITES (2022)

Article Pharmacology & Pharmacy

Integrated Analysis of Metabolomics and Lipidomics in Plasma of T2DM Patients with Diabetic Retinopathy

Chun Ding et al.

Summary: This study investigated the metabolomic and lipidomic characteristics of plasma in patients with diabetic retinopathy (DR). The results showed significant alterations in metabolites and lipids in the plasma of DR patients. These changes were associated with the development of diabetic retinopathy and could serve as potential therapeutic targets.

PHARMACEUTICS (2022)

Article Biochemical Research Methods

Using MetaboAnalyst 5.0 for LC-HRMS spectra processing, multi-omics integration and covariate adjustment of global metabolomics data

Zhiqiang Pang et al.

Summary: Liquid chromatography coupled with high-resolution mass spectrometry (LC-HRMS) is widely used in global metabolomics studies, but there are still challenges in data processing, statistical analysis, and functional interpretation. To overcome these barriers, the MetaboAnalyst platform has been updated to provide step-by-step instructions.

NATURE PROTOCOLS (2022)

Review Endocrinology & Metabolism

Metabolomics of various samples advancing biomarker discovery and pathogenesis elucidation for diabetic retinopathy

Xiaohui Du et al.

Summary: This article reviews the application of metabolomics in diabetic retinopathy (DR) and introduces potential biomarkers such as alanine, lactate, and glutamine that may be related to the pathogenesis of DR.

FRONTIERS IN ENDOCRINOLOGY (2022)

Review Cell Biology

Metabolomics in Diabetic Retinopathy: From Potential Biomarkers to Molecular Basis of Oxidative Stress

Qizhi Jian et al.

Summary: Diabetic retinopathy is a common complication of diabetes and a leading cause of blindness. Metabolomics has great potential in discovering biomarkers and therapeutic targets for early intervention and precise treatment of the disease.
Article Endocrinology & Metabolism

Metabolomic comparison followed by cross-validation of enzyme-linked immunosorbent assay to reveal potential biomarkers of diabetic retinopathy in Chinese with type 2 diabetes

Zongyi Wang et al.

Summary: This study aimed to identify biomarkers in the critical period of development in diabetic retinopathy (DR) in Chinese individuals with type 2 diabetes using targeted and untargeted metabolomics. The results showed that specific metabolites were associated with the severity and progression of DR. Targeted metabolomics exhibited higher accuracy in characterizing serum metabolite expression compared to untargeted metabolomics.

FRONTIERS IN ENDOCRINOLOGY (2022)

Review Medicine, General & Internal

Screening of Diabetic Retinopathy Using Teleophthalmology to Complement Human Resources for Eye Health: A Systematic Review and Meta-Analysis

Thembile Zikhali et al.

Summary: Diabetic retinopathy is a common disease that can cause blindness. The current screening methods rely on ophthalmologists, but limited resources prevent many patients from accessing timely eye care. The use of teleophthalmology offers a promising solution by providing remote eye screenings and early interventions.

CLINICS AND PRACTICE (2022)

Article Endocrinology & Metabolism

Plasma Metabolomics Reveals Metabolic Profiling For Diabetic Retinopathy and Disease Progression

Yu Sun et al.

Summary: This study identified 22 differentially expressed metabolites associated with the occurrence of DR, with pseudouridine levels strongly linked to DR. Additionally, four circulating plasma metabolites were found to be differentially expressed in PDR patients, and a risk score formula based on these metabolites was significantly related to PDR.

FRONTIERS IN ENDOCRINOLOGY (2021)

Review Ophthalmology

Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045 Systematic Review and Meta-analysis

Zhen Ling Teo et al.

Summary: The translated paragraphs provide updated estimates on the global prevalence and number of people with diabetic retinopathy (DR) through 2045. The burden of DR is expected to increase disproportionately in countries in the Middle East and North Africa and the Western Pacific by 2045. Certain ethnic groups such as Hispanics and Middle Easterners with diabetes are more likely to have DR compared to Asians.

OPHTHALMOLOGY (2021)

Article Multidisciplinary Sciences

Plasma amino acids and oxylipins as potential multi-biomarkers for predicting diabetic macular edema

Sang Youl Rhee et al.

Summary: By studying plasma metabolites in T2DM patients, multiple biomarkers including amino acids, organic compounds, and oxylipins were identified to guide DME diagnosis. The combined application of these biomarkers showed high diagnostic value in predicting DME occurrence in non-DME patients.

SCIENTIFIC REPORTS (2021)

Article Endocrinology & Metabolism

Glucagon-like Peptide 1 Receptor Agonists, Diabetic Retinopathy and Angiogenesis: The AngioSafe Type 2 Diabetes Study

Benedicte Gaborit et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)

Article Chemistry, Multidisciplinary

Multiplatform Metabolomics Reveals Novel Serum Metabolite Biomarkers in Diabetic Retinopathy Subjects

Qiuhui Xuan et al.

ADVANCED SCIENCE (2020)

Article Neurosciences

Gabapentin Attenuates Oxidative Stress and Apoptosis in the Diabetic Rat Retina

Mohammad Shamsul Ola et al.

NEUROTOXICITY RESEARCH (2019)

Review Biochemistry & Molecular Biology

Metabolomics of Type 1 and Type 2 Diabetes

Borros Arneth et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Nutrition & Dietetics

Plasma metabolomic profiling of proliferative diabetic retinopathy

Xiao-Rong Zhu et al.

NUTRITION & METABOLISM (2019)

Review Ophthalmology

Metabolomics in the study of retinal health and disease

Ines Lains et al.

PROGRESS IN RETINAL AND EYE RESEARCH (2019)

Article Ophthalmology

Arginine and Carnitine Metabolites Are Altered in Diabetic Retinopathy

Katherine Sumarriva et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2019)

Review Endocrinology & Metabolism

Cataract in diabetes mellitus

Hasan Kiziltoprak et al.

WORLD JOURNAL OF DIABETES (2019)

Article Endocrinology & Metabolism

Plasma glutamine and glutamic acid are potential biomarkers for predicting diabetic retinopathy

Sang Youl Rhee et al.

METABOLOMICS (2018)

Editorial Material Endocrinology & Metabolism

Diabetes and branched-chain amino acids: What is the link?

Zachary Bloomgarden

JOURNAL OF DIABETES (2018)

Review Cell Biology

Metabolomics and Metabolic Diseases: Where Do We Stand?

Christopher B. Newgard

CELL METABOLISM (2017)

Article Endocrinology & Metabolism

Global metabolomics reveals metabolic dysregulation in ischemic retinopathy

Liliana P. Paris et al.

METABOLOMICS (2016)

Article Endocrinology & Metabolism

Plasma Metabonomic Profiling of Diabetic Retinopathy

Liyan Chen et al.

DIABETES (2016)

Review Biochemistry & Molecular Biology

Lipidomics: Techniques, Applications, and Outcomes Related to Biomedical Sciences

Kui Yang et al.

TRENDS IN BIOCHEMICAL SCIENCES (2016)

Article Cardiac & Cardiovascular Systems

Multilevel systems biology modeling characterized the atheroprotective efficiencies of modified dairy fats in a hamster model

Jean-Charles Martin et al.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2015)

Article Biochemical Research Methods

Workflow4Metabolomics: a collaborative research infrastructure for computational metabolomics

Franck Giacomoni et al.

BIOINFORMATICS (2015)

Article Multidisciplinary Sciences

The db/db Mouse: A Useful Model for the Study of Diabetic Retinal Neurodegeneration

Patricia Bogdanov et al.

PLOS ONE (2014)

Article Endocrinology & Metabolism

Association between Related Purine Metabolites and Diabetic Retinopathy in Type 2 Diabetic Patients

Jianfei Xia et al.

INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2014)

Review Biochemistry & Molecular Biology

Glutamate: a truly functional amino acid

John T. Brosnan et al.

AMINO ACIDS (2013)

Article Endocrinology & Metabolism

Global Prevalence and Major Risk Factors of Diabetic Retinopathy

Joanne W. Y. Yau et al.

DIABETES CARE (2012)

Article Multidisciplinary Sciences

Differences between Human Plasma and Serum Metabolite Profiles

Zhonghao Yu et al.

PLOS ONE (2011)

Editorial Material Medicine, General & Internal

Beyond Hemoglobin A1c-Need for Additional Markers of Risk for Diabetic Microvascular Complications

Irl B. Hirsch et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)

Article Medicine, General & Internal

Effects of Medical Therapies on Retinopathy Progression in Type 2 Diabetes.

Emily Y. Chew et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Article Ophthalmology

Metabolic Fingerprints of Proliferative Diabetic Retinopathy: An 1H-NMR-Based Metabonomic Approach Using Vitreous Humor

Ignasi Barba et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2010)

Article Biochemical Research Methods

Analytical Error Reduction Using Single Point Calibration for Accurate and Precise Metabolomic Phenotyping

Frans M. van der Kloet et al.

JOURNAL OF PROTEOME RESEARCH (2009)

Article Biochemistry & Molecular Biology

Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics

Vitali Matyash et al.

JOURNAL OF LIPID RESEARCH (2008)